5411 篇
13916 篇
478298 篇
16343 篇
11779 篇
3948 篇
6564 篇
1254 篇
75732 篇
38177 篇
12196 篇
1672 篇
2874 篇
3423 篇
642 篇
1242 篇
1980 篇
4929 篇
3895 篇
5517 篇
全球肝炎药物市场报告(2015-2019年)
Global Hepatitis Drugs Market 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Product offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Disease overview
Understanding the disease
Classification
Mode of transmission
Epidemiology
Diagnosis
Symptoms
Treatment
PART 06: Key marketed drugs
Hepatitis A
Hepatitis B
Hepatitis C
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by type
Hepatitis A
Hepatitis B
Hepatitis C
PART 09: Market segmentation by MOA
Virus-specific agents
Non-specific agents
PART 10: Geographical segmentation
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
Competitive scenario
Gilead Sciences
Johnson & Johnson
F. Hoffman-La Roche
Merck
GlaxoSmithKline
Vertex Pharmaceuticals
Novartis
Other prominent vendors
PART 17: Key vendor analysis
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Roche
Vertex Pharmaceuticals
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio